CoGenesis® Pan-Cancer 

Genetic Testing for Hereditary Cancers

Our pan-cancer test covers the most relevant and prevalent cancer types, including the 6 cancer types selected by Hong Kong Cancer Expert Working Group on Cancer Prevention and Screening (CEWG)1, stomach cancer and pancreatic cancer2, etc. The purpose of test is to determine if the individual has inherited cancer-related genes and which cancer type do the genes contribute to.
Screening for


hereditary cancer genes in one test
Associated with


most common hereditary cancers
Accurate diagnosis in just


Order Now

About Hereditary Cancer Panel

Who should consider testing

  • People with a family history of any hereditary cancer and would like to know if they carry any cancer-causing genes
  • People with history of hereditary cancer gene mutations in their family and would like to know if they carry the same gene mutations
  • People with a clinical diagnosis of hereditary cancer to confirm the disease-causing genes and whether other family members carry the same gene mutations

What can you learn from the test?

The test targets and analyses genes with high hereditary cancer risk. By finding out the cancer-causing gene(s), it helps you to understand your risk of getting cancer, hence, enables you to start planning for cancer prevention and risk management in order to reduce that risk.

Confirming the diagnosis or cancer related genes at an earlier stage can greatly reduce the cancer risk through risk factor management3.

The Hong Kong government has been proactively raising public’s awareness of cancer prevention since the first release of the Hong Kong Cancer Strategy in 2019. It stated their future direction as well as commitments to stepping up the prevention and control of cancer services in Hong Kong. In this regard, the Hospital Authority (HA) has formulated specific strategies to offer citizens with early detection and diagnosis such as building up the capacity and coverage of regular cancer screening services.

A comprehensive test for hereditary cancer mutations

The test items include:
  • Lung cancer
  • Breast cancer
  • Ovarian cancer
  • Uterine cancer
  • Colorectal cancer
  • Stomach cancer
  • Prostate cancer
  • Skin cancer
  • Pancreatic cancer
  • Renal cancer
  • Endocrine cancer

Discover your cancer risks and take the lead in safeguarding your health

From the report, you are provided with the cancer gene mutations detected and risk score of each tested cancer types. It enables you to recognize what kinds of gene mutations with high predisposing cancer risks you carry, hence devise the risk management plan accordingly to reduce the predisposed cancer risks.

Hong Kong in-house accredited DNA sequencing technologies

Tailor-made using Next-generation sequencing platform CoGenesis®, sample collection is never been so easy. Codex has successfully passed Genomics Quality Assessment (GenQA) and EMQN standard, assuring you a high quality and timely service from Codex.

ISO/IEC 27001 GenQA

The process


Order and receive a saliva collection kit.


Register the sample collection tube barcode online, then take a sample.


Mail the kit back to Codex’s laboratory for analysis.


Results are provided to you securely on the codex website within three to four weeks from receipt of sample.

A high accuracy standard

Steps Accuracy
DNA sequencing 99.9%
Variant calling – SNP >99%*#
Variant calling – Indel >99%*#

* Passed GenQA/UK NEQAS external quality assurance

# The interpretation of sequencing variants is based on the current understanding of the variants at the time it was observed, which may change over time as more information about the genes becomes available. Not all variants are represented in this report.

Order now at our web store

More ways to shop: All Codex Genetics products are also available to order at all 9 Hong Kong Health Check Centres. Contact us for more details.

More hereditary cancer test services


  1. Hong Kong Cancer Strategy 2019。Prevention and Screening. Read:
  2. In recent years, new cases of pancreatic cancer have climbed significantly. It is now the 11th most common cancer type in Hong Kong. It also comes to the 5th in death rates among all cancer types. Former SFH’s Blog -《香港癌症策略》的推出、實施及中期檢討 (11/06/2022) (Chinese only)。Read:
  3. Hong Kong Genome Institute. Hong Kong Genome Project. Available at: